Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from NKGen Biotech ( (NKGN) ) is now available.
On September 25, 2025, NKGen Biotech, Inc. announced a consulting agreement with Yong Man Kim, effective from September 10, 2025. Dr. Kim, who has transitioned from an employee to an independent contractor, will continue as the Chief Scientific Officer while also serving as President of NKMax. This arrangement allows NKGen Biotech to retain Dr. Kim’s expertise, supporting its research and development initiatives.
More about NKGen Biotech
Average Trading Volume: 63,066
Technical Sentiment Signal: Sell
Current Market Cap: $4.94M
For an in-depth examination of NKGN stock, go to TipRanks’ Overview page.